Schizophrenia Clinical Trial
Official title:
Effectiveness of a Joint Crisis Plan (SOS Plan) in Preventing Relapses in Patients Diagnosed With Schizophrenia and Schizoaffective Disorder
The Joint Crisis Plan = SOS Plan is a reference to a particular form of psychiatric advance
directive which involves the patient, the healthcare team, their relatives and a third party
caregiver as intermediary for the project.
The main objective is to evaluate the effectiveness of the SOS Plan (JCP) in terms of the
reduction in hospitalisations within 18 months of its development by comparison to the
standard psychiatric care.
Thus, the investigators' proposal is that SOS Plan's are regularly reassessed every 6 months
and again where there is an unplanned psychiatric readmission that lasts beyond two weeks.
Single blind multicentre randomised trial with parallel control groups.
Effectiveness study of a psychiatric care strategy.
Single blind multicentre randomised trial with parallel control groups.
2 groups:
- SOS Intervention Group: benefits from the SOS Plan in addition to the usual follow-ups
- "Control" Group: receive no additional intervention (only receive the routine
follow-ups)
OBJECTIVES :
- To evaluate the effectiveness of the SOS Plan (JCP) in terms of the reduction in
hospitalisations within 18 months of its development by comparison to the standard
psychiatric care
- To evaluate :
1. the cumulative length of hospitalisations (in days) in the two years following the
development of the SOS plan
2. the type of hospitalisation (voluntary or compulsory)
3. the number of hospitalisations for a given subject
4. the number of crisis situations that may require the use of the SOS Plan
5. the clinical condition of the patient
6. the patient with the most responses to the SOS Plan in socio-demographic terms
7. the patient satisfaction in using the SOS Plan
8. the decisional autonomy during treatment
9. the quality of the therapeutic alliance
10. the length of the meeting to develop the SOS Plan
11. the quality of life
12. the medico-economic impact
EXECUTION OF PRACTICAL RESEARCH :
1. The inclusion visit will be completed apart from a period of acute psychiatric
decompensation, while the patient is capable of consenting to treatment. The inclusion
visit will be completed within a hospital department before the patient is finally
released from hospitalisation or during an outpatient follow-up.
This involves placing the patient on the Positive And Negative Syndrome Scale (PANSS) to
ensure that the patient's clinical condition allows him to consent to treatment. A score
above 95 excludes the patient.
The investigator also outlines the study and schedules visits. The patient then signs
both the information letter and informed consent.
A urine pregnancy test will be carried out on women of childbearing age.
2. Randomisation will be performed by a member of the SOS regional-referral team.
For patients in the SOS Intervention group:
- Preparatory interview with an SOS regional referrer
- SOS Plan development meeting in the presence of the patient, the treating psychiatrist,
one or more relatives, and an SOS regional referrer
For patients in the control group: tracking the continuation of psychiatric care according to
the standard care terms
3 ) Follow-up visits: for the two groups: 4 visits M6, M12, M18, M24 At each visit: meeting
with an independent regional SOS assessor blind to allocation.
For both of the groups:
- Assessment of the clinical condition: placement on the PANSS scale
- Number of psychiatric hospitalisations, types of hospitalisation, duration of
hospitalisation since the last visit
- Satisfaction assessment (numeric scale), of the therapeutic alliance (WAI), of
decision-making autonomy (API), of quality of life (SF-36)
For the SOS Intervention group:
- Updating the SOS Plan after each relapse that leads to an unscheduled psychiatric
hospitalisation lasting more than two weeks.
- Updating the SOS Plan every 6 months in the absence of hospitalisation
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05039489 -
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
Completed |
NCT04503954 -
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
|
N/A | |
Completed |
NCT02831231 -
Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
|
Phase 1 | |
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Completed |
NCT03652974 -
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
|
Phase 4 | |
Recruiting |
NCT04012684 -
rTMS on Mismatch Negativity of Schizophrenia
|
N/A | |
Recruiting |
NCT04481217 -
Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT00212784 -
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)
|
Phase 3 | |
Completed |
NCT04092686 -
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
|
Phase 3 | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Recruiting |
NCT03790345 -
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
|
Phase 2/Phase 3 | |
Recruiting |
NCT05956327 -
Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training
|
N/A | |
Terminated |
NCT03261817 -
A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders
|
N/A | |
Terminated |
NCT03209778 -
Involuntary Memories Investigation in Schizophrenia
|
N/A | |
Completed |
NCT02905604 -
Magnetic Stimulation of the Brain in Schizophrenia or Depression
|
N/A | |
Recruiting |
NCT05542212 -
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia
|
N/A | |
Completed |
NCT04411979 -
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia
|
N/A | |
Terminated |
NCT03220438 -
TMS Enhancement of Visual Plasticity in Schizophrenia
|
N/A |